|
1
|
Joel SP, Halstead FR, Hasleton MD, King JR, Slevin ML, Seymour MT. Determining the maximum tolerated frequency (MTF) of intraperitoneal fluorouracil/folinic acid (FU/FA) administered with adjuvant intravenous FU/FA in patients with colorectal and upper GI tumours. J Clin Oncol 2004. [DOI: 10.1200/jco.2004.22.90140.3668] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Affiliation(s)
- S. P. Joel
- St Bartholomew's Hospital, London, United Kingdom; Cancer Research UK Clinical Centre, Cookridge Hosp, Leeds, United Kingdom; ML Laboratories PLC, St Albans, United Kingdom
| | - F. R. Halstead
- St Bartholomew's Hospital, London, United Kingdom; Cancer Research UK Clinical Centre, Cookridge Hosp, Leeds, United Kingdom; ML Laboratories PLC, St Albans, United Kingdom
| | - M. D. Hasleton
- St Bartholomew's Hospital, London, United Kingdom; Cancer Research UK Clinical Centre, Cookridge Hosp, Leeds, United Kingdom; ML Laboratories PLC, St Albans, United Kingdom
| | - J. R. King
- St Bartholomew's Hospital, London, United Kingdom; Cancer Research UK Clinical Centre, Cookridge Hosp, Leeds, United Kingdom; ML Laboratories PLC, St Albans, United Kingdom
| | - M. L. Slevin
- St Bartholomew's Hospital, London, United Kingdom; Cancer Research UK Clinical Centre, Cookridge Hosp, Leeds, United Kingdom; ML Laboratories PLC, St Albans, United Kingdom
| | - M. T. Seymour
- St Bartholomew's Hospital, London, United Kingdom; Cancer Research UK Clinical Centre, Cookridge Hosp, Leeds, United Kingdom; ML Laboratories PLC, St Albans, United Kingdom
| |
Collapse
|